CytomX Therapeutics (CTMX) Shares Issued (2016 - 2025)
Historic Shares Issued for CytomX Therapeutics (CTMX) over the last 11 years, with Q2 2025 value amounting to $93.4 million.
- CytomX Therapeutics' Shares Issued rose 189985.01% to $93.4 million in Q2 2025 from the same period last year, while for Sep 2025 it was $95.4 million, marking a year-over-year increase of 187047.28%. This contributed to the annual value of $6.9 million for FY2024, which is 7674.34% down from last year.
- CytomX Therapeutics' Shares Issued amounted to $93.4 million in Q2 2025, which was up 189985.01% from $2.1 million recorded in Q4 2024.
- CytomX Therapeutics' 5-year Shares Issued high stood at $107.7 million for Q1 2021, and its period low was $7000.0 during Q1 2022.
- Its 5-year average for Shares Issued is $23.8 million, with a median of $1.3 million in 2022.
- Per our database at Business Quant, CytomX Therapeutics' Shares Issued soared by 489360.22% in 2021 and then tumbled by 9999.35% in 2022.
- CytomX Therapeutics' Shares Issued (Quarter) stood at $107.7 million in 2021, then tumbled by 99.82% to $190000.0 in 2022, then surged by 15348.42% to $29.4 million in 2023, then plummeted by 92.99% to $2.1 million in 2024, then soared by 4439.28% to $93.4 million in 2025.
- Its last three reported values are $93.4 million in Q2 2025, $2.1 million for Q4 2024, and $4.7 million during Q2 2024.